Psychotropic medications have the potential to improve aspects of driving performance, however, this is dependent on factors as perceptual driving context and trip duration. Cognitive and psychomotor aspects of psychiatric disorders often respond to pharmacological treatment, but care must be taken to avoid acute or persistent adverse effects such as sedation or agitation, which could equally elevate crash risk through separate mechanisms.
Abstract